Kimmie Ng

Kimmie Ng

UNVERIFIED PROFILE

Are you Kimmie Ng?   Register this Author

Register author
Kimmie Ng

Kimmie Ng

Publications by authors named "Kimmie Ng"

Are you Kimmie Ng?   Register this Author

100Publications

3091Reads

21Profile Views

Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.

Eur J Cancer 2019 Apr 1;111:82-93. Epub 2019 Mar 1.

Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2019.01.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436990PMC
April 2019

Calcium Intake and Survival after Colorectal Cancer Diagnosis.

Clin Cancer Res 2019 Mar 13;25(6):1980-1988. Epub 2018 Dec 13.

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-2965DOI Listing
March 2019

Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.

Eur J Cancer 2018 11 13;103:98-107. Epub 2018 Sep 13.

Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09598049183110
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2018.07.130DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195453PMC
November 2018

Sedentary Behaviors, TV Viewing Time, and Risk of Young-Onset Colorectal Cancer.

JNCI Cancer Spectr 2018 Nov 25;2(4):pky073. Epub 2019 Jan 25.

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, MO.

View Article

Download full-text PDF

Source
https://academic.oup.com/jncics/article/doi/10.1093/jncics/p
Publisher Site
http://dx.doi.org/10.1093/jncics/pky073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6361621PMC
November 2018

Statin use and pancreatic cancer risk in two prospective cohort studies.

J Gastroenterol 2018 Aug 23;53(8):959-966. Epub 2018 Jan 23.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00535-018-1430-xDOI Listing
August 2018

Prediagnosis Use of Statins Associates With Increased Survival Times of Patients With Pancreatic Cancer.

Clin Gastroenterol Hepatol 2018 08 21;16(8):1300-1306.e3. Epub 2018 Feb 21.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2018.02.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056316PMC
August 2018

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance).

J Clin Oncol 2018 04 28;36(11):1112-1120. Epub 2018 Feb 28.

Temidayo Fadelu, Sui Zhang, Robert J. Mayer, Shuji Ogino, Kimmie Ng, Jeffrey Meyerhardt, and Charles S. Fuchs, Dana-Farber/Partners CancerCare; Shuji Ogino, Kana Wu, Walter Willett, and Edward Giovannucci, Harvard TH Chan School of Public Health; Shuji Ogino, Edward Giovannucci, and Ying Bao, Brigham and Women's Hospital, and Harvard Medical School, Boston, MA; Donna Niedzwiecki and Xing Ye, Alliance Statistics and Data Center, Duke University, Durham; Michael Messino, Southeast Clinical Oncology Research Consortium, Mission Hospitals, Asheville, NC; Leonard B. Saltz, Memorial Sloan Kettering Cancer Center, New York, NY; Rex B. Mowat, Toledo Community Hospital Oncology Program, Toledo, OH; Renaud Whittom, Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada; Alexander Hantel, Loyola University Stritch School of Medicine, Naperville; Al B. Benson, Robert H Lurie Comprehensive Cancer Center, Northwestern University; Hedy L. Kindler, University of Chicago Comprehensive Cancer, Chicago, IL; Daniel M. Atienza, Virginia Oncology Associates, Norfolk, VA; Alan Venook, University of California at San Francisco Comprehensive Cancer Center, San Francisco, CA; and Charles S. Fuchs, Yale Cancer Center, Yale School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.5413DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891130PMC
April 2018

Development and Validation of the PREMM Model for Comprehensive Risk Assessment of Lynch Syndrome.

J Clin Oncol 2017 Jul 10;35(19):2165-2172. Epub 2017 May 10.

Fay Kastrinos and Ashley McFarland, Columbia University Medical Center, New York, NY; Hajime Uno, Chinedu Ukaegbu, Matthew B. Yurgelun, Matthew H. Kulke, Deborah Schrag, Jeffrey A. Meyerhardt, Charles S. Fuchs, Robert J. Mayer, Kimmie Ng, and Sapna Syngal, Dana-Farber Cancer Institute; Carmelita Alvero, Harvard T.H. Chan School of Public Health; Matthew B. Yurgelun, Matthew H. Kulke, Deborah Schrag, Jeffrey A. Meyerhardt, Charles S. Fuchs, Robert J. Mayer, Kimmie Ng, and Sapna Syngal, Harvard Medical School; Sapna Syngal, Brigham and Women's Hospital, Boston, MA; and Ewout W. Steyerberg, University Medical Center Rotterdam, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.6120DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493047PMC
July 2017

Cigarette Smoking and Pancreatic Cancer Survival.

J Clin Oncol 2017 Jun 30;35(16):1822-1828. Epub 2017 Mar 30.

Chen Yuan, Vicente Morales-Oyarvide, Ana Babic, Zhi Rong Qian, Douglas A. Rubinson, Kimmie Ng, Shuji Ogino, Charles S. Fuchs, and Brian M. Wolpin, Dana-Farber Cancer Institute and Harvard Medical School; Chen Yuan, Peter Kraft, Edward L. Giovannucci, Shuji Ogino, Meir J. Stampfer, Howard D. Sesso, and JoAnn E. Manson, Harvard School of Public Health; Ying Bao, Edward L. Giovannucci, Shuji Ogino, Meir J. Stampfer, John Michael Gaziano, Howard D. Sesso, JoAnn E. Manson, and Charles S. Fuchs, Brigham and Women's Hospital and Harvard Medical School; John Michael Gaziano, Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston; Clary B. Clish, Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, MA; and Barbara B. Cochrane, University of Washington School of Nursing, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.2026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455596PMC
June 2017

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer.

J Clin Oncol 2017 Apr 30;35(10):1086-1095. Epub 2017 Jan 30.

Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Chinedu I. Ukaegbu, Lauren K. Brais, Philip G. McNamara, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Dana-Farber Cancer Institute; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Hajime Uno, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Harvard Medical School; Matthew B. Yurgelun, Matthew H. Kulke, Charles S. Fuchs, Jason L. Hornick, Robert J. Mayer, Deborah Schrag, Jeffrey A. Meyerhardt, Kimmie Ng, and Sapna Syngal, Brigham and Women's Hospital, Boston, MA; and Brian A. Allen, John Kidd, Nanda Singh, Anne-Renee Hartman, and Richard J. Wenstrup, Myriad Genetics, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.71.0012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455355PMC
April 2017

To Treat or Not to Treat: Adjuvant Therapy for Stage II Colon Cancer in the Era of Precision Oncology.

J Oncol Pract 2017 04;13(4):242-244

Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2017.022103DOI Listing
April 2017

Vitamin D and Physical Activity in Patients With Colorectal Cancer: Epidemiological Evidence and Therapeutic Implications.

Cancer J 2016 May-Jun;22(3):223-31

From the Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000197DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4922494PMC
January 2017

Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study.

Cancer Prev Res (Phila) 2016 Aug 31;9(8):664-72. Epub 2016 May 31.

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts. Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-16-0053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970876PMC
August 2016

Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.

J Clin Oncol 2016 08 20;34(24):2899-905. Epub 2016 Jun 20.

Chen Yuan, Zhi Rong Qian, Ana Babic, Vicente Morales-Oyarvide, Douglas A. Rubinson, Kimmie Ng, Shuji Ogino, Charles S. Fuchs, and Brian M. Wolpin, Dana-Farber Cancer Institute and Harvard Medical School; Peter Kraft, Edward L. Giovannucci, Shuji Ogino, Meir J. Stampfer, Howard D. Sesso, Julie E. Buring, and JoAnn E. Manson, Harvard School of Public Health; Ying Bao, Edward L. Giovannucci, Shuji Ogino, Meir J. Stampfer, John Michael Gaziano, Howard D. Sesso, JoAnn E. Manson, and Charles S. Fuchs, Brigham and Women's Hospital and Harvard Medical School; John Michael Gaziano, Massachusetts Veterans Epidemiology Research and Information Center, VA Boston Healthcare System, Boston, MA; Barbara B. Cochrane, University of Washington School of Nursing, Seattle, WA; Rowan T. Chlebowski, Los Angeles Biomedical Research Institute at Harbor-University of California, Los Angeles Medical Center, Torrance, CA; and Linda G. Snetselaar, University of Iowa College of Public Health, Iowa City, IA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.3005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012662PMC
August 2016

Circulating Metabolites and Survival Among Patients With Pancreatic Cancer.

J Natl Cancer Inst 2016 Jun 11;108(6):djv409. Epub 2016 Jan 11.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (CY, ZRQ, DAR, KN, SO, MGVH, CSF, BMW); Broad Institute of MIT and Harvard University, Cambridge, MA (CBC, MGVH); Department of Etiology and Carcinogenesis, Cancer Institute and Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China (CW); Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA (JRM, MET, MGVH); Department of Epidemiology (PK, SST, ELG, SO, MJS, JM, HDS, JEM), Department of Biostatistics (PK), and Department of Nutrition (ELG, MJS), Harvard School of Public Health, Boston, MA; Department of Pathology (SO), and Channing Division of Network Medicine (MKT, SST, YB, ELG, MJS, JM, JEM, CSF) and Division of Preventive Medicine (JMG, HDS, JEM), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD (MZ, LTA); Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, Boston, MA (JMG); Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA (GLA); University of Washington School of Nursing, Seattle, WA (BBC); Division of Genomic Stability and DNA repair, Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA (ACK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849356PMC
June 2016

Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.

Br J Nutr 2016 05;115(9):1643-60

1Department of Medical Oncology,Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue,Boston,MA 02215,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0007114516000696DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890569PMC
May 2016

Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.

Cell Rep 2016 Apr 14;15(4):857-865. Epub 2016 Apr 14.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.celrep.2016.03.075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850357PMC
April 2016

Joint effects of colorectal cancer susceptibility loci, circulating 25-hydroxyvitamin D and risk of colorectal cancer.

PLoS One 2014 26;9(3):e92212. Epub 2014 Mar 26.

Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, United States of America; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0092212PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966783PMC
December 2015

Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer.

Cancer Prev Res (Phila) 2015 Dec 17;8(12):1138-45. Epub 2015 Sep 17.

Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts. Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0175DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670783PMC
December 2015

Reduction of Parathyroid Hormone with Vitamin D Supplementation in Blacks: A Randomized Controlled Trial.

BMC Nutr 2015;1. Epub 2015 Dec 17.

Harvard Medical School, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, BostoN; Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40795-015-0024-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743037PMC
December 2015

Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.

Gastroenterology 2015 Sep 27;149(3):614-22. Epub 2015 May 27.

Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, Massachusetts; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.gastro.2015.05.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550565PMC
September 2015

Identification of a common variant with potential pleiotropic effect on risk of inflammatory bowel disease and colorectal cancer.

Carcinogenesis 2015 Sep 12;36(9):999-1007. Epub 2015 Jun 12.

Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA, USA, Department of Epidemiology, Indiana University School of Public Health, Indianapolis, IN, USA,

View Article

Download full-text PDF

Source
http://carcin.oxfordjournals.org/content/early/2015/07/07/ca
Web Search
http://www.carcin.oxfordjournals.org/lookup/doi/10.1093/carc
Publisher Site
http://dx.doi.org/10.1093/carcin/bgv086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573660PMC
September 2015

Response.

J Natl Cancer Inst 2015 Aug 4;107(8). Epub 2015 Jun 4.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (KN, CSF); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609555PMC
August 2015

Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.

J Clin Oncol 2015 Jan 17;33(1):29-35. Epub 2014 Nov 17.

Chen Yuan, Douglas A. Rubinson, Zhi Rong Qian, Shuji Ogino, Kimmie Ng, Megan J. Gorman, Lauren K. Brais, Tingting Li, Matthew H. Kulke, Charles S. Fuchs, and Brian M. Wolpin, Dana-Farber Cancer Institute; Chen Wu, Peter Kraft, Shuji Ogino, Meir J. Stampfer, Frank B. Hu, and Edward L. Giovannucci, Harvard School of Public Health; and Ying Bao, Shuji Ogino, Kimmie Ng, Thomas E. Clancy, Richard S. Swanson, Meir J. Stampfer, Frank B. Hu, Edward L. Giovannucci, Matthew H. Kulke, Charles S. Fuchs, and Brian M. Wolpin, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.5688DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268250PMC
January 2015

Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.

J Natl Cancer Inst 2015 Jan 27;107(1):345. Epub 2014 Nov 27.

: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (KN, JAM, KS, JAC, RJM, SO, CSF); Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA (ATC, ELG, CSF); Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC (DN); Memorial Sloan-Kettering Cancer Center, New York, NY (LBS); Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL (ABB); Toledo Community Hospital Oncology Program, Toledo, OH (PLS); Hopital du Sacre-Coeur de Montreal, Universite de Montreal, Quebec, Canada (RW); Edward Cancer Center, Naperville, IL (AH); Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG); Division of Medical Oncology, University of California at San Francisco, San Francisco, CA (APV); Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (SO); Department of Epidemiology (SO, ELG) and Department of Nutrition (ELG), Harvard School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju345DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271076PMC
January 2015

Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial.

Cancer Epidemiol Biomarkers Prev 2014 Sep 28;23(9):1944-7. Epub 2014 Jun 28.

Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-0522DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4167903PMC
September 2014

Reply to PM Brannon et al.

Am J Clin Nutr 2014 Sep;100(3):984-6

Department of Medical Oncology Dana-Farber Cancer Institute Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3945/ajcn.114.090746DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135506PMC
September 2014

Vitamin D for Prevention and Treatment of Colorectal Cancer: What is the Evidence?

Authors:
Kimmie Ng

Curr Colorectal Cancer Rep 2014 Sep;10(3):339-345

Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, , ,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11888-014-0238-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159193PMC
September 2014

Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D.

Am J Med 2014 Aug 20;127(8):772-8. Epub 2014 Mar 20.

Harvard Medical School, Boston, Mass; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Mass; Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Mass.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2014.02.044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127365PMC
August 2014

Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial.

Am J Clin Nutr 2014 Mar 24;99(3):587-98. Epub 2013 Dec 24.

Department of Medical Oncology (KN, JAM, and CSF) and Center for Community-Based Research (JBS, EG-S, and KME), Dana-Farber Cancer Institute, Boston, MA; the Division of Public Health Sciences, Washington University School of Medicine, St Louis, MO (BFD); the Division of Gastroenterology, Massachusetts General Hospital, Boston, MA (ATC); the Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (ATC, ELG, and CSF); the Division of Pediatrics, Medical University of South Carolina, Charleston, SC (BWH); the Division of General Medicine, Brigham and Women's Hospital, Boston, MA (PDC); the Department of Psychology and Neuroscience, Duke University, Durham, NC (GGB); and the Departments of Nutrition (JBS and ELG) and Social and Behavioral Sciences (KME), Harvard School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
https://academic.oup.com/ajcn/article/99/3/587/4577418
Publisher Site
http://dx.doi.org/10.3945/ajcn.113.067777DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3927692PMC
March 2014

Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial.

J Natl Cancer Inst 2013 Dec 14;105(23):1789-98. Epub 2013 Nov 14.

Affiliations of authors: Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA (SO, XL, YI, MY, NJM, KN, RJM, JAM, CSF); Department of Pathology (SO), Channing Division of Network Medicine, Department of Medicine (DS, CSF), and Department of Surgery (MMB), Brigham and Women's Hospital and Harvard Medical School, Boston, MA (SO); Department of Epidemiology (SO, DS) and Department of Biostatistics (DS) , Harvard School of Public Health, Boston, MA; Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC (DN); Memorial Sloan-Kettering Cancer Center, New York, NY (LBS); Hôpital du Sacré-Coeur de Montréal, Montreal, Canada (RW); Loyola University Stritch School of Medicine, Maywood, IL (AH); current: Edward Cancer Center, Naperville, IL (AH); Northwestern University, Chicago, IL (ABB); Toledo Community Hospital Oncology Program, Toledo, OH (RBM); Division of Medical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH (RMG).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848984PMC
December 2013

Genetic predictors of circulating 25-hydroxyvitamin d and risk of colorectal cancer.

Cancer Epidemiol Biomarkers Prev 2013 Nov 27;22(11):2037-46. Epub 2013 Aug 27.

Authors' Affiliations: Program in Molecular and Genetic Epidemiology, Department of Epidemiology, Departments of Nutrition, and Biostatistics, Harvard School of Public Health; Department of Medicine, and Channing Division of Network Medicine, Brigham and Women's Hospital; Division of Gastroenterology, Massachusetts General Hospital; Department of Medicine, Harvard Medical School; Gastrointestinal Malignancy Program, and Medical-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Public Health Sciences Division, Fred Hutchinson Cancer Research Center; Department of Epidemiology, University of Washington School of Public Health, Seattle, Washington; Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina; Divisions of Cancer Epidemiology and Genetics, and Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda; University of Maryland, School of Medicine, Baltimore, Maryland; Service de Génétique Médicale, CHU Nantes, Nantes, France; Divisions of Clinical Epidemiology and Aging Research and Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany; Division of Research, Kaiser Permanente Medical Care Program, Oakland; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California; Translational Genomics Research Institute, Phoenix, Arizona; Department of Surgery, Toronto General Hospital; Ontario Institute for Cancer Research; Departments of Medical Biophysics and Molecular Genetics, University of Toronto, Toronto; Faculty of Medicine, The University of Ottawa, Ottawa, Ontario, Canada; Department of Environmental Medicine, Division of Epidemiology, New York University School of Medicine, New York; Department of Social and Preventive Medicine, University of Buffalo, Buffalo, New York; Melborne School of Population Health, The University of Melbourne, Melbourne, Victoria, Australia; Epidemiology Pro

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0209DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818310PMC
November 2013

Prediagnostic body mass index and pancreatic cancer survival.

J Clin Oncol 2013 Nov 21;31(33):4229-34. Epub 2013 Oct 21.

Chen Yuan, Shuji Ogino, Kimmie Ng, Zhi Rong Qian, Douglas A. Rubinson, and Brian M. Wolpin, Dana-Farber Cancer Institute; Ying Bao, Shuji Ogino, Kimmie Ng, Meir J. Stampfer, Edward L. Giovannucci, and Brian M. Wolpin, Brigham and Women's Hospital, Harvard Medical School; and Chen Wu, Peter Kraft, Shuji Ogino, Meir J. Stampfer, and Edward L. Giovannucci, Harvard School of Public Health, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.7532DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821012PMC
November 2013

Effect of vitamin D supplementation on blood pressure in blacks.

Hypertension 2013 Apr;61(4):779-85

Renal Division and Kidney Clinical Research Institute, Brigham and Women's Hospital, 41 Ave Louis Pasteur, Suite 120, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/HYPERTENSIONAHA.111.00659DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775458PMC
April 2013

Reported behavior of eating anything at anytime and risk of colorectal cancer in women.

Int J Cancer 2012 Mar 21;130(6):1395-400. Epub 2011 Jul 21.

Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.26150DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3193565PMC
March 2012

Dietary insulin load, dietary insulin index, and colorectal cancer.

Cancer Epidemiol Biomarkers Prev 2010 Dec 5;19(12):3020-6. Epub 2010 Oct 5.

Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-10-0833DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3005557PMC
December 2010

Effects of vitamin D in colorectal cancer.

Authors:
Kimmie Ng

Clin Adv Hematol Oncol 2010 Aug;8(8):533-4

Gastrointestinal Cancer Center, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
August 2010

Microsatellite instability and adjuvant fluorouracil chemotherapy: a mismatch?

J Clin Oncol 2010 Jul 24;28(20):3207-10. Epub 2010 May 24.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2010.28.9314
Publisher Site
http://dx.doi.org/10.1200/JCO.2010.28.9314DOI Listing
July 2010

Clinical activity of gemcitabine plus pertuzumab in platinum-resistant ovarian cancer, fallopian tube cancer, or primary peritoneal cancer.

J Clin Oncol 2010 Mar 9;28(7):1215-23. Epub 2009 Nov 9.

Department of Gynecology and Obstetrics, Emory University School of Medicine, Woodruff Memorial Research Bldg, 1639 Pierce Dr 4305, Atlanta, GA 30322, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.22.3354DOI Listing
March 2010

PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.

Cancer Epidemiol Biomarkers Prev 2010 Mar 3;19(3):822-31. Epub 2010 Mar 3.

Department of Medical Oncology, Dana-FarberCancer Institute and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-09-1154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837535PMC
March 2010

Vitamin D receptor expression is associated with PIK3CA and KRAS mutations in colorectal cancer.

Cancer Epidemiol Biomarkers Prev 2009 Oct 29;18(10):2765-72. Epub 2009 Sep 29.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-09-0490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768137PMC
October 2009

Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.

J Clin Oncol 2009 Jan 8;27(2):176-85. Epub 2008 Dec 8.

Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.9945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645084PMC
January 2009

Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.

J Clin Oncol 2008 Jun;26(18):2984-91

Division of Medical Oncology, Dana-Farber Cancer Institute Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2007.15.1027
Publisher Site
http://dx.doi.org/10.1200/JCO.2007.15.1027DOI Listing
June 2008

Adjuvant and neoadjuvant approaches in gastric cancer.

Cancer J 2007 May-Jun;13(3):168-74

Dana-Farber Cancer Institute, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00130404-200705000-000
Publisher Site
http://dx.doi.org/10.1097/PPO.0b013e318074e351DOI Listing
January 2008

Targeting the epidermal growth factor receptor in metastatic colorectal cancer.

Crit Rev Oncol Hematol 2008 Jan 19;65(1):8-20. Epub 2007 Nov 19.

Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2007.09.006DOI Listing
January 2008